Section
2018 eCQMs
For the 2018 reporting year, Sevocity offers workflows and reports for 23 eCQMs.
About eCQM Workflows
Workflows have been developed to assist Sevocity users with the 2018 electronic clinical quality measures. Although there may be other methods capable of meeting the measures, only the recommended workflows are approved to meet the measure requirements.
These workflows are designed as a supplemental resource and are not a substitute for the eligibility and requirements of the programs for which the eCQMs are being reported.
Terminology Specific to eCQM Workflows
Active Diagnosis: An active diagnosis is an ICD‑9 or ICD‑10 code added in the Assessment tab of an encounter which has neither been resolved nor inactivated
Eligible Clinician (EC): a Medicare provider who qualifies for MIPS participation
Eligible Provider (EP): a Medicaid provider who qualifies for the Medicaid Promoting Interoperability Program
Measurement Period: For the 2018 performance year, the Measurement Period is defined as January 1, 2018 through December 31, 2018
CMS 2v7: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS 50v6: Closing the Referral Loop: Receipt of Specialist Report
CMS 68v7: Documentation of Current Medications in the Medical Record
CMS 69v6: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS 75v6: Children Who Have Dental Decay or Cavities
CMS 117v6: Childhood Immunization Status
CMS 122v6: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
CMS 123v6: Diabetes: Foot Exam
CMS 124v6: Cervical Cancer Screening
CMS 125v6: Breast Cancer Screening
CMS 127v6: Pneumococcal Vaccination Status for Older Adults
CMS 130v6: Colorectal Cancer Screening
CMS 134v6: Diabetes: Medical Attention for Nephropathy
CMS 138v6: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS 139v6: Falls: Screening for Future Falls Risk
CMS 146v6: Appropriate Testing for Children with Pharyngitis
CMS 147v7: Preventive Care and Screening: Influenza Immunization
CMS 153v6: Chlamydia Screening for Women
CMS 156v6: Use of High-Risk Medications in the Elderly
CMS 165v6: Controlling High Blood Pressure
CMS 166v7: Use of Imaging Studies for Low Back Pain
What’s Next?
Articles
-
CMS 125v6: Breast Cancer Screening
Measure: Percentage of women 50-74 years of age who had a mammogram to screen for breast cancer Measure Type High Priority Measure Scoring Process No A higher percentage indicates better quality Denominator Women 51-74 years of age with a visit during the measurement period Numerator Women with one or more mammograms during the measurement period […]
-
CMS 122v6: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
Measure: Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period Measure Type High Priority Measure Scoring Outcome Yes A lower percentage indicates better quality Denominator Patients 18-75 years of age with diabetes with a visit during the measurement period Numerator Patients whose most recent HbA1c […]
-
CMS 139v6: Falls: Screening for Future Falls Risk
Measure: Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period Measure Type High Priority Measure Scoring Process Yes A higher percentage indicates better quality Denominator Patients aged 65 years and older with a visit during the measurement period Numerator Patients who were screened for […]
-
CMS 165v6: Controlling High Blood Pressure
Measure: Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90mmHg) during the measurement period Measure Type High Priority Measure Scoring Outcome Yes A higher percentage indicates better quality Denominator Patients 18-85 years of age who had a diagnosis of essential hypertension within the […]
-
CMS 124v6: Cervical Cancer Screening
Measure: Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: Women age 21-64 who had cervical cytology performed every 3 years Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years Measure Type High Priority Measure Scoring Process No A higher […]